Back
Allogene Therapeutics Stock Predictions
Sponsored
ALLO
Sponsored
Trump wins! Dow to 75,000? Details here
See the explosive "Document 20" details here.
Sell
15
ALLO
Allogene Therapeutics
Last Price:
2.27
Seasonality Move:
6.59%
7 Day Trial
ALL ACCESS PASS
$
7
"This Changes Everything" - Trump Hands Millions Massive IRS Gift
Learn More HereAllogene Therapeutics Stock Forecast
-
Is Allogene Therapeutics Stock Undervalued?
The current Allogene Therapeutics [ALLO] share price is $2.27. The Score for ALLO is 15, which is 70% below its historic median score of 50, and infers higher risk than normal. - ALLO is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
Will Allogene Therapeutics Stock Go Up Next Year?
Data Unavailable
Allogene Therapeutics Stock Rating
Data Unavailable
Allogene Therapeutics Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
allogene.com
52-Week Data
52-Week High:
5.78
52-Week Low:
2.01
Prediction Charts
Market Cap:
475.96M
Price in USD:
2.27
Volume:
3.08M
Beta:
0.92
Technical Analysis
SMA50:
2.75
SMA100:
2.68
SMA200:
3.17
52-Wk Change:
-16.54%
Stock Predictions
-
Is Allogene Therapeutics stock public?
Yes, Allogene Therapeutics is a publicly traded company. -
What is the Allogene Therapeutics stock quote today?
The Allogene Therapeutics stock price is 2.27 USD today. -
How to buy Allogene Therapeutics stock online?
You can buy Allogene Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
Date | Opening | Closing | Minimum | Maximum |
---|---|---|---|---|
Oct-29 | 2.68 | 2.80 | 3.01 | 2.67 |
Oct-30 | 2.74 | 2.64 | 3.01 | 2.64 |
Oct-31 | 2.64 | 2.55 | 2.73 | 2.54 |
Nov-1 | 2.57 | 2.72 | 2.83 | 2.57 |
Nov-4 | 2.73 | 3.00 | 3.03 | 2.66 |
Nov-5 | 2.96 | 2.99 | 3.04 | 2.88 |
Nov-6 | 3.05 | 3.22 | 3.29 | 2.99 |
Nov-7 | 3.26 | 3.19 | 3.36 | 3.17 |
Nov-8 | 3.24 | 3.08 | 3.26 | 2.95 |
Nov-11 | 3.05 | 3.07 | 3.17 | 2.99 |
Nov-12 | 3.01 | 2.84 | 3.05 | 2.83 |
Nov-13 | 2.86 | 2.73 | 2.95 | 2.71 |
Nov-14 | 2.72 | 2.46 | 2.75 | 2.46 |
Nov-15 | 2.52 | 2.27 | 2.52 | 2.26 |
Allogene Therapeutics Earnings
Data Unavailable
Allogene Therapeutics Forecast Revenue Growth
Data Unavailable
- Analysts estimate an earnings increase this quarter of $0.03 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.68 per share, and a decrease next year of $0.06 per share.
* Allogene Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.